Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gliosarcoma × Automobiles × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Rhabdoid Tumor 3 Pinealoma 3 Neuroectodermal Tumors, Primitive 3 Neoplasms, Germ Cell and Embryonal 3 Medulloblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Glioma 3 Ependymoma 3 Choroid Plexus Carcinoma 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Recurrence 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colorectal Neoplasms 2 Burkitt Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, B-Cell 1 Gliosarcoma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Dendritic Cell Sarcoma, Interdigitating 1 CD7-Positive Hematological Malignancies 1

Interventions

Temozolomide 80 Radiotherapy 47 Bevacizumab 29 Irinotecan 18 Radiation 15 Erlotinib Hydrochloride 14 Carmustine 13 Magnetic Resonance Spectroscopy 12 O(6)-benzylguanine 10 Chemotherapy, Adjuvant 10 sargramostim 8 Thalidomide 8 Imatinib Mesylate 8 Carboplatin 8 Gene Expression Profiling 6 Filgrastim 6 Drug Therapy 6 Surgical Procedures, Operative 5 Radiotherapy, Intensity-Modulated 5 Hydroxyurea 5 Gefitinib 5 pembrolizumab 4 aldesleukin 4 Topotecan 4 Immunohistochemistry 4 Etoposide 4 Dasatinib 4 Celecoxib 4 Biopsy 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02664363 2023-02-17

ExCeL

Duke University

Phase 1 Terminated

3 enrolled 8 charts

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡